Pfizer abandons Alzheimer’s and Parkinson’s research

The company doesn't see a future in it
dementia man

Pfizer has announced that it is pulling out of early-stage research into Alzheimer’s and Parkinson’s disease after investing heavily in the area in recent years.

The pharmaceutical giant has said in a statement that its money can be spent more productively elsewhere.